Research Appraisalother

Multimodal personalised executive function intervention (E-Fit) for school-aged children with complex congenital heart disease in Switzerland: a randomised controlled feasibility study

BMJ openSchmid, Alenka S, Ehrler, Melanie, Bunge, Silvia A et al.8 May 2026DOI

Clinical Snapshot

70CEBM
Evidence: Moderateother

PICO Framework

P — PopulationChildren aged 10-12 years with complex congenital heart disease (cCHD) without genetic diagnosis, who had infant open-heart surgery and reported executive function difficulties (BRIEF T-scores ≥60)
I — Intervention8-week multimodal E-Fit intervention including computerised executive function training (CogniFit, 3×20 min/week), weekly remote 1:1 strategy coaching, and analogue games
C — ComparatorControl group completing activity logs only
O — OutcomesPrimary: Feasibility measures (acceptability, demand, implementation, practicality, integration). Secondary: Executive function improvements (BRIEF), neuropsychological testing, psychosocial variables at 8 weeks and 4-month follow-up

Bottom Line

This Swiss feasibility study demonstrates that a multimodal executive function intervention (E-Fit) is acceptable and implementable for school-aged children with complex congenital heart disease. The 8-week programme combining computerised training, individual coaching, and analogue games showed promising preliminary efficacy with moderate effect sizes for behavioural regulation and social responsiveness. Key feasibility metrics were met: 90% retention rate, successful implementation of coaching sessions, and good home integration. However, adherence to computerised training was suboptimal at 67%, highlighting the need for enhanced motivational strategies. While single-blinding limitations and small sample size restrict definitive conclusions, the results support progression to a full-scale efficacy trial. For Australian clinicians, this intervention model offers a potentially valuable approach for addressing executive function deficits in children with congenital heart disease, with remote delivery components particularly suited to our healthcare geography. The intervention's multimodal approach aligns with contemporary understanding of executive function development and could complement existing developmental support services.

Evidence: Moderate

Key Findings

  • P Value: Not reported in abstract

  • Effect Size: Moderate effect sizes favouring intervention group: Hedge's g = -0.408 to -0.903 for Behavioral Regulation Index

  • Primary Outcome: Feasibility demonstrated across all domains: acceptable intervention, 90% retention rate, good implementation fidelity, and successful integration into home settings

  • Nnt Or Sensitivity: Not applicable for feasibility study; effect sizes suggest potential clinical benefit

  • Confidence Interval: Not reported in abstract

Clinical Application

Intervention appears feasible in clinical practice with remote delivery components, though computerised training adherence may need improvement strategies Relevant to Australian paediatric cardiology and developmental services; remote delivery model suits Australian geography; intervention components align with NDIS support frameworks for children with developmental needs Children aged 10-12 years with complex congenital heart disease experiencing executive function difficulties, particularly those with BRIEF T-scores ≥60

Abstract

OBJECTIVE: To explore the feasibility of a novel multimodal executive function intervention in school-aged children with complex congenital heart disease (cCHD). DESIGN: Single-centre, single-blinded, randomised-controlled 8-week multimodal personalised executive function intervention (E-Fit) study. Outcomes were measured throughout the intervention, post-intervention (T1) and at 4-month follow-up (T2). SETTING: Tertiary care centre between May 2022 and May 2024. PARTICIPANTS: Children 10 to 12 years (M=11.0, SD=0.9) with cCHD without a genetic diagnosis with infant open-heart surgery and reported difficulties (T-scores ≥60) on any of the summary scales of the parent- or teacher-reported Behavior Rating Inventory for Executive Function (BRIEF). INTERVENTIONS: Children with cCHD were randomly assigned to one of two groups: the intervention or the control group. The 8-week intervention was multimodal including three modalities: (1) computerised executive function (EF) training 3×20 min/week with CogniFit; (2) a weekly, remote standardised 1:1 individual EF strategy coaching; (3) analogue games played at convenience. The control group completed activity logs. FEASIBILITY MEASURES: Acceptability: Acceptance and Feasibility Scale (AFS) and coach-rated engagement during coaching sessions. Demand: Number of completed computerised training, strategy coaching and analogue game sessions. IMPLEMENTATION: E-Fit Fidelity Measurement System, assessing adherence to core components. Practicality: Retention rate. Integration: AFS integration items. Exploratory efficacy: BRIEF, neuropsychological EF testing and psychosocial variables at baseline, post-intervention (8 weeks) and at 4-month follow-up. RESULTS: We recruited 42 participants (Nfemale=20). Acceptability: The intervention was acceptable, with moderate observed engagement. Demand: median number of computerised training sessions completed was 16 of 24 sessions (67%, (IQR; 6 to 19)), all children attended all scheduled coaching sessions, analogue games were played in total a median of 9 times (IQR 4 to 14). IMPLEMENTATION: Coaching sessions could be implemented by the coaches as intended. Practicality: Overall retention rate was 90%. Integration: E-Fit was well integrable into the home setting. Exploratory efficacy favoured the intervention group with improvements in the parent-rated Behavioral Regulation Index of the BRIEF (adjusted Hedge's (gA1) = -0.408 to -0.903) and in social responsiveness (gA1 = -0.427 to -0.521) at T1 and at T2. CONCLUSIONS: E-Fit is a feasible intervention suggesting EF and social responsiveness improvements in children with cCHD. Motivational strategies to improve adherence to computerised training should be refined before a full-scale efficacy trial. TRIAL REGISTRATION NUMBER: NCT05198583.

References

  1. 1.Schmid, A. S., Ehrler, M., Bunge, S. A., Kretschmar, O., Landolt, M. A., Rousson, V., Tuura, R. O., Wehrle, F. M., & Latal, B. (2026). Multimodal personalised executive function intervention (E-Fit) for school-aged children with complex congenital heart disease in Switzerland: a randomised controlled feasibility study. BMJ Open, 16(5), e107681. https://doi.org/10.1136/bmjopen-2025-107681
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service